Synthetic cannabinoids are manufactured clandestinely with little quality control and are distributed as herbal spice for smoking or as bulk compound for mixing with a solvent and inhalation via electronic vaporizers. Intoxication with synthetic cannabinoids has been associated with seizure, excited delirium, coma, kidney damage, and other disorders. The chemical alterations produced by heating these structurally novel compounds for consumption are largely unknown. The current study found that some products of combustion retained high affinity, were more efficacious, and were potent in laboratory animals; whereas, other compounds had low affinity and efficacy and were devoid of cannabimimetic activity. Degradants that retained affinity and efficacy also substituted in drug discrimination tests for the prototypical synthetic cannabinoid 1-pentyl-3-(1-naphthoyl)indole (JWH-018), and are likely to produce psychotropic effects in humans. Hence, it is important to take into consideration the actual chemical exposures that occur during use of synthetic cannabinoid formulations to better comprehend the relationships between dose and effect. (Publisher abstract modified)
Downloads
Similar Publications
- Assessing Screw Length Impact on Bone Strain in Proximal Humerus Fracture Fixation Via Surrogate Modelling
- Evaluation of Cannabis Product Mislabeling: The Development of a Unified Cannabinoid LC-MS/MS Method to Analyze E-liquids and Edible Products
- High-throughput LC-PDA Method for Determination of Δ9-THC and Related Cannabinoids in Cannabis Sativa